HBEGF expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.47649999957278E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.80439999997173E-06 |
Normal-vs-Stage2 |
2.30569999999375E-05 |
Normal-vs-Stage3 |
8.05169999562594E-08 |
Normal-vs-Stage4 |
4.39280000041897E-07 |
Stage1-vs-Stage2 |
9.778800E-01 |
Stage1-vs-Stage3 |
4.814400E-02 |
Stage1-vs-Stage4 |
2.918800E-01 |
Stage2-vs-Stage3 |
2.402600E-01 |
Stage2-vs-Stage4 |
5.165000E-01 |
Stage3-vs-Stage4 |
4.824800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.41879999982342E-07 |
Normal-vs-AfricanAmerican |
1.50531999999481E-05 |
Normal-vs-Asian |
5.5901999695962E-09 |
Caucasian-vs-AfricanAmerican |
9.399400E-01 |
Caucasian-vs-Asian |
6.099600E-03 |
AfricanAmerican-vs-Asian |
1.019710E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.10879999959401E-07 |
Normal-vs-Female |
2.02229999999304E-05 |
Male-vs-Female |
1.564140E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.962350E-04 |
Normal-vs-Age(41-60Yrs) |
1.01500000004862E-06 |
Normal-vs-Age(61-80Yrs) |
2.48069999986278E-07 |
Normal-vs-Age(81-100Yrs) |
9.95179999999651E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.231400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.310200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.768600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.301000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.777000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.821000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.336400E-01 |
Normal-vs-Grade 2 |
1.61622000000028E-05 |
Normal-vs-Grade 3 |
3.91169999724994E-08 |
Normal-vs-Grade 4 |
1.90039999958813E-07 |
Grade 1-vs-Grade 2 |
5.653600E-02 |
Grade 1-vs-Grade 3 |
3.826200E-02 |
Grade 1-vs-Grade 4 |
4.899900E-02 |
Grade 2-vs-Grade 3 |
1.958900E-03 |
Grade 2-vs-Grade 4 |
4.712100E-02 |
Grade 3-vs-Grade 4 |
7.080800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.25049999999405E-06 |
Normal-vs-ccB subtype |
7.60060000049023E-07 |
ccA subtype-vs-ccB subtype |
6.508800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.99670000036834E-07 |
Normal-vs-N1 |
2.13639994584014E-09 |
N0-vs-N1 |
5.537400E-03 |
|
|